The Role of Acetylcholinesterase in Alzheimer's Disease
Author Information
Author(s): Jean Létitia, Thomas Benjamin, Tahiri-Alaoui Abdessamad, Shaw Michael, Vaux David J.
Primary Institution: Sir William Dunn School of Pathology, University of Oxford
Hypothesis
Does acetylcholinesterase (AChE) contribute to the formation of amyloid fibrils in Alzheimer's disease?
Conclusion
The study found that proteolytic cleavage of AChE leads to the formation of amyloidogenic fragments that can promote the aggregation of amyloid-β, suggesting a new pathological trigger in Alzheimer's disease.
Supporting Evidence
- IDE and NEP were shown to cleave AChE, leading to the formation of amyloidogenic fragments.
- These fragments were found to promote the aggregation of amyloid-β, a key player in Alzheimer's disease.
- The study identified a conformational switch in AChE that enhances its amyloidogenic potential.
Takeaway
Scientists discovered that a protein called acetylcholinesterase can change and help form harmful clumps in the brain that are linked to Alzheimer's disease.
Methodology
The study used mass spectrometry and reverse-phase HPLC to analyze the effects of IDE and NEP on AChE fragments and their ability to promote Aβ fibrilization.
Limitations
The study primarily focused on in vitro experiments, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website